Scantox Group, Headquarters
Scantox A/S
The Scantox Group Headquarters has since 1977 been based in Ejby, Lille Skensved, 30 minutes from Copenhagen. This is the same location in which the company was originally founded.
Scantox is one of the largest employers in the region, and a sought after partner for pharma and biotech companies around the world for a unique expertise and long track record. Current premises cover an area exceeding 8,500 m2, where all phases of the scientific research process take place.
The company has over the years made continuous investment in advanced housing facilities according to EU Directive 2010/63/EU, as well as in state-of-the-art laboratories, and meet and exceed the industry’s highest quality standards.
Scantox is fully licensed by Danish Authorities, and all processes are carried out on the most reliable equipment available in the industry today.
Scantox business unit: Regulatory Toxicology
Scantox A/S
Hestehavevej 36A, Ejby
4623 Lille Skensved
Denmark
Tel: +45 5686 1500
Sales: clientservice@scantox.com
Human Resources: hr@scantox.com
Finance: finance@scantox.com
Marketing: marketing@scantox.com
Scantox Austria
- Preclinical research services in neurodegenerative and rare diseases
- Numerous cell culture models including brain slices and iPSCs for neurodegenerative and rare diseases and corresponding analysis
- In vivo research in transgenic and induced rodent models of Alzheimer’s, Parkinson’s, Amyotrophic lateral sclerosis, Huntington’s, Multiple sclerosis, as well as several lysosomal storage diseases and mental disorders
- Various treatment and surgery options for POC and efficacy studies
- Behavioral testing of rodents for general health, cognitive, motor, and social deficits as well as anxiety, depression, and lateral lesions
- Mouse and rat housing and breeding in AAALAC-accredited animal facility
- Provision of cell culture and rodent tissues of performed studies as well as rodent Biobank
- Histological analysis of various animal and human tissues by general staining and immunofluorescent labeling followed by rater-independent quantification
- Biochemical analysis of cell culture, rodent and human tissues for biomarkers by quantification of mRNA, protein, enzyme activity
Scantox business unit: Discovery
Formerly: QPS Neuropharmacology / Part of Scantox since: 2024
Scantox Neuro GmbH
Parkring 12
8074 Grambach, Austria
office-austria@scantox.com
+43 (0) 316 258111
Scantox Denmark
Scantox Ballerup
- Formulation Development to achieve products with unique profiles
- Analytical Development and validation of QC methods to assure the quality of the products
- ICH stability testing according to regulatory guidelines to establish shelf life of products
- GMP Manufacturing of oral and topical products in our GMP approved studies
- Technology transfer of manufacturing process to CMO for commercial manufacture
- Primary and secondary packaging and labelling of Investigational Medicinal Products
- QA, QC and QP release of Investigational Medicinal Products
- Generating the CMC part of the regulatory package e.g. IMPDs, INDs and other regulatory documents
Scantox business unit: Pharmaceutical Development & Analytical
Formerly: Solural Pharma ApS / Part of Scantox since: 2023
Scantox Ballerup
Energivej 42
2750 Ballerup, Denmark
info-ballerup@scantox.com
+45 5115 7729
+45 2566 7575
Scantox Sweden
Scantox Lund
- Exploratory and efficacy studies in diverse animal models, including transgenic and non-transgenic rodents, rabbits and minipigs.
- Strong focus on wound healing, oncology, immunology, and neurology.
- Custom tailored studies in a wide range of administration routes for dosing and blood sampling for various indications available.
- State-of-the-art pharma class facilities located at Medicon Village, Lund and animal facilities approved for BSL2 studies.
Formerly: Timeline Bioresearch / Part of Scantox since: 2022
Scantox Lund
Medicon Village
Scheelevägen 2, Building 404,
223 63 Lund, Sweden
info-lund@scantox.com
+46 73 093 63 34
Scantox Solna
- Exploratory and regulatory studies in rodents and non-rodents. Most administration routes, sampling techniques and animal models for most indications available. Tailor-made surgical techniques.
- A strong focus on oncology, immunology, vaccine and infection studies, all available at BSL1-BSL3.
- GLP compliant studies in AAALAC accredited facilities.
- Clinical pathology and immunology analyses on site, histopathology analyses in house. Different imaging capabilities available in collaboration with the Karolinska Hospital.
Scantox business unit: Discovery / Regulatory Toxicology
Formerly: Adlego Biomedical / Part of Scantox since: 2022
Scantox Solna
Karolinska Science Park
Nobels väg 16
171 65 Solna, Sweden
info-solna@scantox.com
+46 (0) 8 121 615 70
Scantox Gothenburg
- Bespoke analyses within organic chemistry
- Analytical method development and validations (according to ICH and/or EMA guidelines)
- Release testing of raw materials and finished pharmaceutical product (GMP).
- Bioanalysis from toxicological (GLP) and clinical (GCP) studies.
- Instruments: LC-QQQ, LC-DAD/FLD, GC-FID, GC-MS, Dissolution, Disintegration, KarlFischer, Spectophotometer, FT-IR, TOC (Total Organic Carbon), Sub-visible Particles (Ph.Eur. 2.9.19 method 1), TLC, Leak test (Container closure integrity), Capillary viscometer, Osmometer, Refractometer
Scantox business unit: Pharmaceutical Development & Analytical
Formerly: Q&Q Labs / Part of Scantox since: 2023
Scantox Gothenburg
AstraZeneca BioVentureHub
Pepparedsleden 3
431 83 Mölndal, Sweden
info-gothenburg@scantox.com
+46 (0) 31 242 200
